A 26-year-old is the fourth person to die shortly after changing from a branded version of the anti-epilepsy drug lamotrigine to a generic version, Logem.
Videographer Dom Thomas and investigative reporter Guyon Espiner sat down on Friday afternoon with Pharmac's Medical Director Dr Ken Clark. He asked Dr Clark if the concerns of epilepsy patients and their families are justified.
